Centrum Doskonało¶ci w dziedzinie Medycyny Molekularnej
   
       
     
Lecture by Prof. Boris Zhivotovsky
   
     

Lodz, Rectorate of Medical University (Main Hall),
November 13th (Thursday)
,
13:00

Programme:
MOLECULAR MECHANISMS OF APOPTOSIS.
THE ROLE IN DEVELOPMENT AND DISEASES

Rectorate of Medical University of Lodz
4 Kosciuszki Ave.
90-419 Lodz


Prof. Boris Zhivotovsky

received his Ph.D. in Biochemistry and Radiobiology in 1975 and his Dr. Sci. in 1989 in St. Petersburg (Russia). In 1991 he joined the group of Sten Orrenius at Karolinska Institutet, where later he was appointed Professor of Toxicology. His initial work on mechanisms of radiation-induced lymphoid cell death led to continued interest in understanding how radiation kills cells. At present his general research interest is focused on cell death mechanisms of importance for the elimination of cancer cells - in particular, on deficiencies in the apoptotic machinery of tumor cells resistant to treatment. His group has made notable contributions to the characterization of caspases and their translocation during apoptosis. Boris Zhivotovsky is an author of more than 120 publications in a peer review journals. In 1987 he received the USSR State Prize in Science and Technology (Gold Medal) for his research. At present he serves as an Adjunct Professor at Moscow State University, General Secretary of the European Cell Death Organization, Member of the Board of Directors at the International Cell Death Society and Swedish National Coordinator at the EC Program: Apoptosis and programmed cell death: molecular mechanisms and applications in biotechnology.

Boris Zhivotovsky is the organizer and leader of Annual courses for graduate students on Apoptosis: Theory and Methods and Apoptosis in Cancer at the Karolinska Institutet, the Organizer and a Member of the Organizing Committee’s on many Meetings, including the last 5 Euroconferences on Apoptosis and the Nobel Conference: ”Apoptosis: Molecular Mechanisms and Medical Implications”. He is an Editorial Board Member of Cell Cycle, Cancer Biology and Therapy, Radiobiology.